EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies
Publication
, Conference
Davis, R; Deak, K; Carney, J; Glass, C
Published in: LABORATORY INVESTIGATION
March 1, 2020
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
March 1, 2020
Volume
100
Issue
SUPPL 1
Start / End Page
1767 / 1768
Location
Los Angeles, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Davis, R., Deak, K., Carney, J., & Glass, C. (2020). EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies. In LABORATORY INVESTIGATION (Vol. 100, pp. 1767–1768). Los Angeles, CA: NATURE PUBLISHING GROUP.
Davis, Richard, Kristen Deak, John Carney, and Carolyn Glass. “EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies.” In LABORATORY INVESTIGATION, 100:1767–68. NATURE PUBLISHING GROUP, 2020.
Davis R, Deak K, Carney J, Glass C. EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies. In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2020. p. 1767–8.
Davis, Richard, et al. “EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies.” LABORATORY INVESTIGATION, vol. 100, no. SUPPL 1, NATURE PUBLISHING GROUP, 2020, pp. 1767–68.
Davis R, Deak K, Carney J, Glass C. EZH2 Expression in SMARCA4-mutant Primary Lung Malignancies. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2020. p. 1767–1768.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
March 1, 2020
Volume
100
Issue
SUPPL 1
Start / End Page
1767 / 1768
Location
Los Angeles, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences